Best Stocks Under $20 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $20.00 (20 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Glencore OTCMKTS:GLNCY$8.25 +0.05 (+0.61%) As of 02/20/2025 03:59 PM EasternGlencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about GlencoreMarket Capitalization$50.02 billionConsensus RatingStrong BuyVolume1.82 million sharesAverage Volume895,873 sharesToday's Range$8.13▼$8.3150-Day Range$8.20▼$9.38 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Serve Robotics NASDAQ:SERV$12.29 -0.81 (-6.18%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Serve Robotics Inc designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. More about Serve RoboticsMarket Capitalization$545.64 millionConsensus RatingStrong BuyConsensus Price Target$19.50 (+58.7% Upside)Volume2.88 million sharesAverage Volume13.30 million sharesToday's Range$12.46▼$13.423. Green Thumb Industries OTCMKTS:GTBIF$6.99 +0.00 (+0.04%) As of 02/20/2025 03:59 PM EasternGreen Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. More about Green Thumb IndustriesMarket Capitalization$1.48 billionP/E Ratio29.14Consensus RatingStrong BuyConsensus Price Target$16.50 (+136.0% Upside)Volume495,227 sharesAverage Volume499,337 shares4. Denison Mines NYSEAMERICAN:DNN$1.58 -0.01 (-0.32%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.40 billionP/E Ratio-156.50Consensus RatingStrong BuyConsensus Price Target$3.00 (+90.5% Upside)Volume8.00 million sharesAverage Volume40.02 million shares5. J Sainsbury OTCMKTS:JSAIY$12.60 +0.01 (+0.08%) As of 02/20/2025 03:50 PM EasternJ Sainsbury plc, together with its subsidiaries, engages in the food, general merchandise and clothing retailing, and financial services activities in the United Kingdom and the Republic of Ireland. More about J SainsburyMarket Capitalization$7.36 billionConsensus RatingStrong BuyVolume20,341 sharesAverage Volume33,699 sharesToday's Range$12.44▼$12.6450-Day Range$12.59▼$14.346. Mereo BioPharma Group NASDAQ:MREO$2.82 -0.06 (-1.92%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$438.30 millionConsensus RatingBuyConsensus Price Target$7.83 (+178.3% Upside)Volume62,258 sharesAverage Volume1.11 million sharesToday's Range$2.83▼$2.907. Mirion Technologies NYSE:MIR$16.36 -0.29 (-1.71%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. More about Mirion TechnologiesMarket Capitalization$3.81 billionP/E Ratio-86.31Consensus RatingBuyConsensus Price Target$19.25 (+17.6% Upside)Volume177,102 sharesAverage Volume2.11 million shares8. OnKure Therapeutics NASDAQ:OKUR$5.42 -0.05 (-0.82%) As of 10:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$18.10 millionP/E Ratio-0.44Consensus RatingBuyConsensus Price Target$36.00 (+564.8% Upside)Volume3,097 sharesAverage Volume96,729 shares9. Franklin BSP Realty Trust NYSE:FBRT$13.16 -0.04 (-0.27%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Benefit Street Partners operates as a self-managed real estate investment trust (REIT). BSP earns income from investing in a leveraged portfolio of residential mortgage pass-through securities consisting almost exclusively of adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the government-sponsored enterprises (GSEs)), or by an agency of the federal government, Government National Mortgage Association (Ginnie Mae). More about Franklin BSP Realty TrustMarket Capitalization$1.08 billionP/E Ratio15.86Consensus RatingBuyConsensus Price Target$15.63 (+18.8% Upside)Volume68,462 sharesAverage Volume370,025 shares10. Aviva OTCMKTS:AVVIY$12.75 +0.07 (+0.55%) As of 02/20/2025 03:50 PM EasternAviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. More about AvivaMarket Capitalization$16.97 billionConsensus RatingBuyVolume8,370 sharesAverage Volume21,711 sharesToday's Range$12.66▼$12.7550-Day Range$11.59▼$12.9811. Bioceres Crop Solutions NASDAQ:BIOX$4.70 -0.05 (-0.95%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop SolutionsMarket Capitalization$294.42 millionP/E Ratio234.87Consensus RatingBuyConsensus Price Target$9.88 (+110.3% Upside)Volume25,134 sharesAverage Volume296,422 shares12. Hudbay Minerals NYSE:HBM$7.25 -0.36 (-4.77%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Hudbay Minerals Inc, a diversified mining company, focuses on the exploration, development, operation, and optimization of properties in North and South America. More about Hudbay MineralsMarket Capitalization$2.85 billionP/E Ratio40.14Consensus RatingBuyConsensus Price Target$11.17 (+54.1% Upside)Volume1.13 million sharesAverage Volume6.28 million shares13. enCore Energy NASDAQ:EU$2.70 -0.05 (-1.64%) As of 10:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$499.73 millionP/E Ratio-9.59Consensus RatingBuyConsensus Price Target$6.50 (+141.2% Upside)Volume230,604 sharesAverage Volume1.51 million shares14. Achieve Life Sciences NASDAQ:ACHV$3.18 -0.04 (-1.09%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life SciencesMarket Capitalization$109.53 millionP/E Ratio-2.82Consensus RatingBuyConsensus Price Target$14.80 (+364.7% Upside)Volume18,631 sharesAverage Volume286,249 shares15. Quince Therapeutics NASDAQ:QNCX$1.42 -0.04 (-2.41%) As of 10:42 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$62.26 millionP/E Ratio-1.14Consensus RatingBuyConsensus Price Target$9.50 (+571.4% Upside)Volume15,230 sharesAverage Volume126,877 shares16. Solid Biosciences NASDAQ:SLDB$5.79 -0.21 (-3.52%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid BiosciencesMarket Capitalization$234.92 millionP/E Ratio-1.90Consensus RatingBuyConsensus Price Target$15.40 (+166.0% Upside)Volume679,591 sharesAverage Volume3.38 million shares17. Cardiol Therapeutics NASDAQ:CRDL$1.25 -0.05 (-3.46%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$103.68 millionP/E Ratio-3.22Consensus RatingBuyConsensus Price Target$8.40 (+569.3% Upside)Volume31,309 sharesAverage Volume258,619 shares18. Aura Biosciences NASDAQ:AURA$7.66 +0.03 (+0.39%) As of 10:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aura Biosciences, Inc, a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. More about Aura BiosciencesMarket Capitalization$383.62 millionP/E Ratio-4.44Consensus RatingBuyConsensus Price Target$23.00 (+200.3% Upside)Volume51,580 sharesAverage Volume136,148 shares19. GeoVax Labs NASDAQ:GOVX$1.61 -0.02 (-1.23%) As of 10:26 AM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$15.20 millionConsensus RatingBuyConsensus Price Target$14.20 (+782.0% Upside)Volume44,028 sharesAverage Volume546,184 sharesToday's Range$1.61▼$1.6920. ARS Pharmaceuticals NASDAQ:SPRY$11.53 -0.25 (-2.12%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.ARS Pharmaceuticals, Inc, a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. More about ARS PharmaceuticalsMarket Capitalization$1.12 billionP/E Ratio-22.61Consensus RatingBuyConsensus Price Target$28.80 (+149.8% Upside)Volume217,507 sharesAverage Volume1.26 million shares21. Reviva Pharmaceuticals NASDAQ:RVPH$1.64 +0.01 (+0.61%) As of 10:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$54.94 millionP/E Ratio-1.48Consensus RatingBuyConsensus Price Target$11.40 (+595.1% Upside)Volume126,341 sharesAverage Volume1.97 million shares22. Nkarta NASDAQ:NKTX$2.10 -0.05 (-2.42%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$147.14 millionP/E Ratio-1.11Consensus RatingBuyConsensus Price Target$15.00 (+615.0% Upside)Volume156,541 sharesAverage Volume1.00 million shares23. Aclaris Therapeutics NASDAQ:ACRS$2.28 -0.03 (-1.30%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$162.50 millionP/E Ratio-4.38Consensus RatingBuyConsensus Price Target$11.00 (+382.5% Upside)Volume64,762 sharesAverage Volume783,220 shares24. Rezolve AI NASDAQ:RZLV$2.66 +0.08 (+3.22%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$457.14 millionConsensus RatingBuyConsensus Price Target$6.40 (+140.3% Upside)Volume1.71 million sharesAverage Volume7.98 million sharesToday's Range$2.63▼$2.7625. Zevra Therapeutics NASDAQ:ZVRA$7.86 +0.04 (+0.45%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Zevra Therapeutics, Inc discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. More about Zevra TherapeuticsMarket Capitalization$419.57 millionP/E Ratio-3.99Consensus RatingBuyConsensus Price Target$21.57 (+174.3% Upside)Volume55,078 sharesAverage Volume381,763 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Stock Skids—How Much Further Can It Fall? Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive SoundHound AI Stock at a Crossroads—Is a Bottom in Sight? SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It? Buffett’s Billion-Dollar Bet: Will Constellation Brands Pay Off? Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite? Medtronic’s Expansion Gains Momentum—Time for a Market Shift? 3 Stocks With Robust Growth Outlooks Insiders Are Buying Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
